Evaluation of VeriStrat, a serum proteomic test, in the randomized, open-label, Phase 3 LUX-Lung 8 trial of afatinib versus erlotinib for the second-line treatment of advanced squamous cell carcinoma of the lung
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2016-10, Vol.27, p.vi428-vi428 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | vi428 |
|---|---|
| container_issue | |
| container_start_page | vi428 |
| container_title | Annals of oncology |
| container_volume | 27 |
| creator | Goss, G. Lee, K.H. Felip, E. Cobo, M. Syrigos, K. Goker, E. Georgioulias, V. Guclu, S.Z. Isla, D. Min, Y.J. Morabito, A. Dupuis, N. Chand, V.K. Solca, F. Krämer, N. Gibson, N. Ehrnrooth, E. Soria, J.C. |
| description | |
| doi_str_mv | 10.1093/annonc/mdw383.38 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdw383_38</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419448618</els_id><sourcerecordid>S0923753419448618</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1818-52ff0d8a9fa53326e174739cdac6ee275b563db3bcfcee509ef20e7fcf171f353</originalsourceid><addsrcrecordid>eNp1kc9u1DAQxi0EEsu2d47zAJvWjjf_uKGqUKSVqESLeosm9pgaOfZiO1vBa_aFSBquHEYjfZrfNzP6GHsv-IXgnbxE74NXl6N-kq28kO0rthFV3RUt34vXbMO7UhZNJfdv2buUfnLO667sNuz5-oRuwmyDh2DgO0X7LUfMO0BIFKcRjjFkCqNVkCnNuvWQHwkiej2rf0jvIBzJFw4Hcju4fcREIOFw_1AcJv8DWsjRolvc0cyLvB3gRDFNCSi6sAomxBfXRCp4XTjracYI80g-v6D6hF6RhvRrwjHMsCLnQGFU1ocRl5nFwM0rz9gbgy7R-b--Zfefru-uborD189frj4eCiVa0RZVaQzXLXYGKynLmkSzb2SnNKqaqGyqoaqlHuSgjCKqeEem5NQYZUQjjKzklvHVV8WQUiTTH6MdMf7uBe-XUPo1lH4NpZ9ryz6sCM13nSzFPilLy2M2ksq9Dvb_8F-b8pw7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Evaluation of VeriStrat, a serum proteomic test, in the randomized, open-label, Phase 3 LUX-Lung 8 trial of afatinib versus erlotinib for the second-line treatment of advanced squamous cell carcinoma of the lung</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Goss, G. ; Lee, K.H. ; Felip, E. ; Cobo, M. ; Syrigos, K. ; Goker, E. ; Georgioulias, V. ; Guclu, S.Z. ; Isla, D. ; Min, Y.J. ; Morabito, A. ; Dupuis, N. ; Chand, V.K. ; Solca, F. ; Krämer, N. ; Gibson, N. ; Ehrnrooth, E. ; Soria, J.C.</creator><creatorcontrib>Goss, G. ; Lee, K.H. ; Felip, E. ; Cobo, M. ; Syrigos, K. ; Goker, E. ; Georgioulias, V. ; Guclu, S.Z. ; Isla, D. ; Min, Y.J. ; Morabito, A. ; Dupuis, N. ; Chand, V.K. ; Solca, F. ; Krämer, N. ; Gibson, N. ; Ehrnrooth, E. ; Soria, J.C.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdw383.38</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2016-10, Vol.27, p.vi428-vi428</ispartof><rights>2016 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1818-52ff0d8a9fa53326e174739cdac6ee275b563db3bcfcee509ef20e7fcf171f353</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Goss, G.</creatorcontrib><creatorcontrib>Lee, K.H.</creatorcontrib><creatorcontrib>Felip, E.</creatorcontrib><creatorcontrib>Cobo, M.</creatorcontrib><creatorcontrib>Syrigos, K.</creatorcontrib><creatorcontrib>Goker, E.</creatorcontrib><creatorcontrib>Georgioulias, V.</creatorcontrib><creatorcontrib>Guclu, S.Z.</creatorcontrib><creatorcontrib>Isla, D.</creatorcontrib><creatorcontrib>Min, Y.J.</creatorcontrib><creatorcontrib>Morabito, A.</creatorcontrib><creatorcontrib>Dupuis, N.</creatorcontrib><creatorcontrib>Chand, V.K.</creatorcontrib><creatorcontrib>Solca, F.</creatorcontrib><creatorcontrib>Krämer, N.</creatorcontrib><creatorcontrib>Gibson, N.</creatorcontrib><creatorcontrib>Ehrnrooth, E.</creatorcontrib><creatorcontrib>Soria, J.C.</creatorcontrib><title>Evaluation of VeriStrat, a serum proteomic test, in the randomized, open-label, Phase 3 LUX-Lung 8 trial of afatinib versus erlotinib for the second-line treatment of advanced squamous cell carcinoma of the lung</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kc9u1DAQxi0EEsu2d47zAJvWjjf_uKGqUKSVqESLeosm9pgaOfZiO1vBa_aFSBquHEYjfZrfNzP6GHsv-IXgnbxE74NXl6N-kq28kO0rthFV3RUt34vXbMO7UhZNJfdv2buUfnLO667sNuz5-oRuwmyDh2DgO0X7LUfMO0BIFKcRjjFkCqNVkCnNuvWQHwkiej2rf0jvIBzJFw4Hcju4fcREIOFw_1AcJv8DWsjRolvc0cyLvB3gRDFNCSi6sAomxBfXRCp4XTjracYI80g-v6D6hF6RhvRrwjHMsCLnQGFU1ocRl5nFwM0rz9gbgy7R-b--Zfefru-uborD189frj4eCiVa0RZVaQzXLXYGKynLmkSzb2SnNKqaqGyqoaqlHuSgjCKqeEem5NQYZUQjjKzklvHVV8WQUiTTH6MdMf7uBe-XUPo1lH4NpZ9ryz6sCM13nSzFPilLy2M2ksq9Dvb_8F-b8pw7</recordid><startdate>20161001</startdate><enddate>20161001</enddate><creator>Goss, G.</creator><creator>Lee, K.H.</creator><creator>Felip, E.</creator><creator>Cobo, M.</creator><creator>Syrigos, K.</creator><creator>Goker, E.</creator><creator>Georgioulias, V.</creator><creator>Guclu, S.Z.</creator><creator>Isla, D.</creator><creator>Min, Y.J.</creator><creator>Morabito, A.</creator><creator>Dupuis, N.</creator><creator>Chand, V.K.</creator><creator>Solca, F.</creator><creator>Krämer, N.</creator><creator>Gibson, N.</creator><creator>Ehrnrooth, E.</creator><creator>Soria, J.C.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20161001</creationdate><title>Evaluation of VeriStrat, a serum proteomic test, in the randomized, open-label, Phase 3 LUX-Lung 8 trial of afatinib versus erlotinib for the second-line treatment of advanced squamous cell carcinoma of the lung</title><author>Goss, G. ; Lee, K.H. ; Felip, E. ; Cobo, M. ; Syrigos, K. ; Goker, E. ; Georgioulias, V. ; Guclu, S.Z. ; Isla, D. ; Min, Y.J. ; Morabito, A. ; Dupuis, N. ; Chand, V.K. ; Solca, F. ; Krämer, N. ; Gibson, N. ; Ehrnrooth, E. ; Soria, J.C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1818-52ff0d8a9fa53326e174739cdac6ee275b563db3bcfcee509ef20e7fcf171f353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Goss, G.</creatorcontrib><creatorcontrib>Lee, K.H.</creatorcontrib><creatorcontrib>Felip, E.</creatorcontrib><creatorcontrib>Cobo, M.</creatorcontrib><creatorcontrib>Syrigos, K.</creatorcontrib><creatorcontrib>Goker, E.</creatorcontrib><creatorcontrib>Georgioulias, V.</creatorcontrib><creatorcontrib>Guclu, S.Z.</creatorcontrib><creatorcontrib>Isla, D.</creatorcontrib><creatorcontrib>Min, Y.J.</creatorcontrib><creatorcontrib>Morabito, A.</creatorcontrib><creatorcontrib>Dupuis, N.</creatorcontrib><creatorcontrib>Chand, V.K.</creatorcontrib><creatorcontrib>Solca, F.</creatorcontrib><creatorcontrib>Krämer, N.</creatorcontrib><creatorcontrib>Gibson, N.</creatorcontrib><creatorcontrib>Ehrnrooth, E.</creatorcontrib><creatorcontrib>Soria, J.C.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Goss, G.</au><au>Lee, K.H.</au><au>Felip, E.</au><au>Cobo, M.</au><au>Syrigos, K.</au><au>Goker, E.</au><au>Georgioulias, V.</au><au>Guclu, S.Z.</au><au>Isla, D.</au><au>Min, Y.J.</au><au>Morabito, A.</au><au>Dupuis, N.</au><au>Chand, V.K.</au><au>Solca, F.</au><au>Krämer, N.</au><au>Gibson, N.</au><au>Ehrnrooth, E.</au><au>Soria, J.C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of VeriStrat, a serum proteomic test, in the randomized, open-label, Phase 3 LUX-Lung 8 trial of afatinib versus erlotinib for the second-line treatment of advanced squamous cell carcinoma of the lung</atitle><jtitle>Annals of oncology</jtitle><date>2016-10-01</date><risdate>2016</risdate><volume>27</volume><spage>vi428</spage><epage>vi428</epage><pages>vi428-vi428</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdw383.38</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2016-10, Vol.27, p.vi428-vi428 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdw383_38 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | Evaluation of VeriStrat, a serum proteomic test, in the randomized, open-label, Phase 3 LUX-Lung 8 trial of afatinib versus erlotinib for the second-line treatment of advanced squamous cell carcinoma of the lung |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T00%3A22%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20VeriStrat,%20a%20serum%20proteomic%20test,%20in%20the%20randomized,%20open-label,%20Phase%203%20LUX-Lung%208%20trial%20of%20afatinib%20versus%20erlotinib%20for%20the%20second-line%20treatment%20of%20advanced%20squamous%20cell%20carcinoma%20of%20the%20lung&rft.jtitle=Annals%20of%20oncology&rft.au=Goss,%20G.&rft.date=2016-10-01&rft.volume=27&rft.spage=vi428&rft.epage=vi428&rft.pages=vi428-vi428&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdw383.38&rft_dat=%3Celsevier_cross%3ES0923753419448618%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753419448618&rfr_iscdi=true |